Results 181 to 190 of about 2,100,146 (305)

Explosive drug information in the time of COVID-19. [PDF]

Can Pharm J (Ott), 2021
Schulz M, Schumacher PM, Schneider J, Said A, Laufs U.   +4 more
europepmc   +1 more source

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance

Aging and Cancer, EarlyView.
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang, Zhong Fan, Runmeng Liu, Xiaotian Zhang   +3 more
wiley   +1 more source

Sistema Brasileiro de Informação sobre Medicamentos - SISMED

Cadernos de Saúde Pública
Foram descritas as atividades do farmacêutico especialista em informação sobre medicamentos (IM) e caracterizados os Centros de Informação sobre Medicamentos (CIMs), deixando claro o que não são e o que são - mitos e fatos.
Carlos C. F. Vidotti, Rogério Hoefler, Emília Vitória Silva, Gun Bergsten-Mendes   +3 more
doaj  

A Critical Juncture for Drug Information and Evidence-Based Voices. [PDF]

J Pediatr Pharmacol Ther
Kier K.
europepmc   +1 more source

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Aging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel, S. Tissera, E. Paul, J. Zalcberg, R. G. Stirling   +4 more
wiley   +1 more source

Design and development of a mobile application for drug information and other health data for users and patients of pharmacies and outpatient pharmaceutical services. [PDF]

Explor Res Clin Soc Pharm
Agudelo R, Granados J, Ceballos M, Pereañez JA.   +3 more
europepmc   +1 more source

Usefulness of a Drug Information Resources Website (SAGASU-DI) Created Based on Inquiries to Clinical Pharmacists. [PDF]

Healthcare (Basel), 2022
Murasaka T, Kato H, Sudo H, Iwamoto T.
europepmc   +1 more source

Super‐Refractory Status Epilepticus (SRSE) in a Patient With Compound Heterozygous OPA1 Variants: Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Super‐Refractory Status Epilepticus (SRSE) is a rare, life‐threatening neurological emergency with unclear etiology in many cases. Mitochondrial dysfunction, often due to disease‐causing genetic variants, is increasingly recognized as a cause, with each gene producing distinct pathophysiological mechanisms.
Pouria Mohammadi, Lara Basovic, Christopher Michael McGraw   +2 more
wiley   +1 more source

Comparison of MyDispense with in-person simulation in drug information training of pharmacy curriculum - a randomized cross-over study. [PDF]

BMC Med Educ
Amirthalingam P, Pakkir Mohamed SH, Veeramani VP, Nagoor Thangam MM, Alanazi MF, Dhanasekaran M, Mani V, Prabahar K, Ali MAS.   +8 more
europepmc   +1 more source

Preference and usage pattern of mobile medical apps for drug information purposes among hospital pharmacists in Sarawak, Malaysia. [PDF]

BMC Med Inform Decis Mak, 2022
Kho BP, Wong SMA, Chiu JWT, Liew E.
europepmc   +1 more source